PIK3CD and posterior cortical atrophy: To further verify this hypothesis, the LNCaP and MDA PCa 2b cells expressing the differential PIK3CD-L or PIK3CD-S were treated with pan-PI3K and PI3Kδ-specific drugs to examine the drug efficacies against these PCa cells with distinct PIK3CD-L and PIK3CD-S expression profiles.